Literature DB >> 12834488

Carcinoma and eccrine syringofibroadenoma: a report of five cases.

Torsten Bjarke1, Annika Ternesten-Bratel, Marianne Hedblad, Alf Rausing.   

Abstract

BACKGROUND: In the literature, there are some reports of cases interpreted as carcinomatous transformation in eccrine syringofibroadenoma (ESFA).
RESULTS: We have studied five cases with a histological mixture of ESFA and carcinoma. The carcinoma had a partial squamous cell cytology in all cases. In two of them, there was partial poroma and porocarcinoma picture. However, the squamous cell parts had some features of porocarcinoma such as retiform configuration and funnel-like cavities with luminal carcinoembryonic antigen (CEA) positivity. Also, there was strong epithelial membrane antigen (EMA) positivity. Therefore, we interpret the cases as porocarcinomas with extensive squamous metaplasia. One case had a life-long precursor lesion with a histologic picture interpreted as ESFA, with progressing cytologic atypia. Another case had ectodermal dysplasia, a condition known to predispose to ESFA and a precursor lesion of long-standing, probably benign ESFA. In these two cases, we interpret the carcinoma as a secondary development in a benign ESFA. Three cases were otherwise healthy people with precursor lesions of 10-, 5-, and 2-year duration. We do not know for certain if the ESFA preceded the carcinoma in these cases but we think that it probably did.
CONCLUSIONS: We recommend that diagnosed ESFA shall be completely excised or followed, in view of the risk of developing carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834488     DOI: 10.1034/j.1600-0560.2003.00072.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

1.  Solitary eccrine syringofibroadenoma--Case Report.

Authors:  Caroline Bertolini Bottino; Tais Ferreira Guimarães; Flávio Rezende Gomes; Antonio Macedo D'Acri; Ricardo Barbosa Lima; Carlos José Martins
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

2.  Solitary Eccrine Syringofibroadenoma of the Dorsum of Hand.

Authors:  Peimei Zhou; Fan Li; Hongjie Liu; Lin Wang
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

3.  Eccrine Syringofibroadenoma in a Patient with Long-Standing Exfoliative Dermatitis.

Authors:  Eun Jung Ko; Kui Young Park; Hyun Jung Kwon; Joo Hyun Shim; Seong Jun Seo
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

4.  A Solitary Facial Nodule with an Uncharacteristic Histopathology.

Authors:  Aditya Kumar Bubna; Maharaja Krishnamoorthy; Barathi Gunabooshanam
Journal:  Int J Trichology       Date:  2016 Jul-Sep

Review 5.  Connexin channels in congenital skin disorders.

Authors:  Evelyn Lilly; Caterina Sellitto; Leonard M Milstone; Thomas W White
Journal:  Semin Cell Dev Biol       Date:  2016-01-13       Impact factor: 7.727

6.  A case report of reactive solitary eccrine syringofibroadenoma.

Authors:  Anup K Tiwary; J Firdous; Dharmendra K Mishra; Shyam S Chaudhary
Journal:  Indian Dermatol Online J       Date:  2017 Jan-Feb

7.  Reactive Eccrine Syringofibroadenomatosis Presenting as Bilateral Plantar Hyperkeratosis.

Authors:  Nidhi Singh; Laxmisha Chandrashekar; Pragasam Shakthi; Devinder Mohan Thappa; Bhawana Ashok Badhe; Mary Theresa Sylvia
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

8.  Eccrine syringofibroadenoma (ESFA): a report of two cases.

Authors:  Bhakinai Temnithikul; Suthep Jerasutus; Poonnawis Sudtikoonaseth; Nataya Voravutinon; Tanawatt Kootiratrakarn; Pinnaree Kattipathananpong
Journal:  Dermatol Pract Concept       Date:  2016-01-31

9.  Reactive Eccrine Syringofibroadenoma Associated with Neuropathy, Venous Stasis, and Diabetic Foot Ulcer.

Authors:  Thirawut Sirikham; Salinee Rojhirunsakool; Vasanop Vachiramon
Journal:  Case Rep Dermatol       Date:  2016-06-02

10.  Reactive Eccrine Syringofibroadenoma on the Heel, Clinically Mimicking Squamous Cell Carcinoma.

Authors:  Yuri Sugita; Teruhiko Makino; Kotaro Matsui; Tadamichi Shimizu
Journal:  Case Rep Dermatol Med       Date:  2019-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.